Literature DB >> 25697741

Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.

Truc T Tran1, Hannah R Palmer2, Marion R Weimar3, Cesar A Arias4, Gregory M Cook3, Barbara E Murray5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25697741      PMCID： PMC4447780          DOI： 10.1093/cid/civ130

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.

Authors:  M R Weinstein; H Dedier; J Brunton; I Campbell; J M Conly
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium.

Authors:  J K Chia; M M Nakata; S S Park; R P Lewis; B McKee
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

3.  Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin.

Authors:  C A O'Donovan; P Fan-Havard; F T Tecson-Tumang; S M Smith; R H Eng
Journal:  Diagn Microbiol Infect Dis       Date:  1994-02       Impact factor: 2.803

4.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Joao B Xavier; Lauren Lipuma; Carles Ubeda; Jenna Goldberg; Asia Gobourne; Yeon Joo Lee; Krista A Dubin; Nicholas D Socci; Agnes Viale; Miguel-Angel Perales; Robert R Jenq; Marcel R M van den Brink; Eric G Pamer
Journal:  Clin Infect Dis       Date:  2012-06-20       Impact factor: 9.079

5.  Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR.

Authors:  Janet M Manson; Stefanie Keis; John M B Smith; Gregory M Cook
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use.

Authors:  Janet M Manson; John M B Smith; Gregory M Cook
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.

Authors:  John B Bossaer; Philip D Hall; Elizabeth Garrett-Mayer
Journal:  Support Care Cancer       Date:  2010-01-13       Impact factor: 3.603

8.  Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility.

Authors:  M Armstrong-Evans; M Litt; M A McArthur; B Willey; D Cann; S Liska; S Nusinowitz; R Gould; A Blacklock; D E Low; A McGeer
Journal:  Infect Control Hosp Epidemiol       Date:  1999-05       Impact factor: 3.254

9.  Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes.

Authors:  Xiang Qin; Jessica R Galloway-Peña; Jouko Sillanpaa; Jung Hyeob Roh; Sreedhar R Nallapareddy; Shahreen Chowdhury; Agathe Bourgogne; Tina Choudhury; Donna M Muzny; Christian J Buhay; Yan Ding; Shannon Dugan-Rocha; Wen Liu; Christie Kovar; Erica Sodergren; Sarah Highlander; Joseph F Petrosino; Kim C Worley; Richard A Gibbs; George M Weinstock; Barbara E Murray
Journal:  BMC Microbiol       Date:  2012-07-07       Impact factor: 3.605

Review 10.  Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.

Authors:  Vincent C C Cheng; Jonathan H K Chen; Josepha W M Tai; Sally C Y Wong; Rosana W S Poon; Ivan F N Hung; Kelvin K W To; Jasper F W Chan; Pak-Leung Ho; Chung-Mau Lo; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-09-23       Impact factor: 3.090
View more
  5 in total

1.  Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.

Authors:  Haroon Mohammad; Waleed Younis; Lu Chen; Christine E Peters; Joe Pogliano; Kit Pogliano; Bruce Cooper; Jianan Zhang; Abdelrahman Mayhoub; Eric Oldfield; Mark Cushman; Mohamed N Seleem
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

2.  The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faecium.

Authors:  Ana M Guzmán Prieto; Jessica Wijngaarden; Johanna C Braat; Malbert R C Rogers; Eline Majoor; Ellen C Brouwer; Xinglin Zhang; Jumamurat R Bayjanov; Marc J M Bonten; Rob J L Willems; Willem van Schaik
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 3.  Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.

Authors:  Rubén Cebrián; Qian Li; Pablo Peñalver; Efres Belmonte-Reche; María Andrés-Bilbao; Ricardo Lucas; María Violante de Paz; Oscar P Kuipers; Juan Carlos Morales
Journal:  J Nat Prod       Date:  2022-05-27       Impact factor: 4.803

4.  Multilevel selection of bcrABDR-mediated bacitracin resistance in Enterococcus faecalis from chicken farms.

Authors:  Mu-Ya Chen; Felipe Lira; Hua-Qing Liang; Rui-Ting Wu; Jia-Hong Duan; Xiao-Ping Liao; José L Martínez; Ya-Hong Liu; Jian Sun
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

5.  Selective digestive decontamination with oral colistin plus gentamicin for persistent bacteraemia caused by non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae in a neutropenic patient.

Authors:  Maria Spencer-Sandino; Roberto Riquelme-Neira; William C Shropshire; An Q Dinh; Gerardo González-Rocha; Paulina González-Muñoz; Alejandra Vera-Leiva; Rafael Araos; Blake Hanson; Cesar A Arias; José M Munita
Journal:  JAC Antimicrob Resist       Date:  2021-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.